Skip to content
OpenCapital
Get started

Pelthos Therapeutics Inc. PTHS Q1 2026 earnings

Reported May 14, 2026 · Before market open

Revenue$10.9MBeat by $468.3KDiluted EPS-$3.09Beat by $0.36
Revenue estimate$10.4M
EPS estimate-$3.45

Next report

Aug 12, 2026 (in a month)
Revenue estimate$15.2M
EPS estimate-$2.95

Financials

Q1 2026

Income statement

See full
Revenue$10.9M—
Gross profit$9.2M—
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M—
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K—
Free cash flow-$13.3M-2,008%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$94.4M—
Enterprise value$92.07M—
P/S3.4×—

Profitability

See full
Gross margin79.6%—
Operating margin-157.7%—
Net margin-186.2%—

Returns & leverage

See full
Debt / equity0.8×—
Current ratio2.8×+2.6×

Segments

By segment

See full
Commercial operations$10.7M—
Research and Development operations$241.0K—

Versus estimates

Revenue

Q1 2026$10.9MBeat by $468.3K
Q4 2025$9.4MBeat by $298.5KQ3 2025$7.4MMiss by $3.0M

Diluted EPS

Q1 2026-$3.09Beat by $0.36
Q4 2025-$2.83Beat by $1.12Q3 2025-$5.30Miss by $4.63Q2 2025-$5.38Miss by $2.28

Ask the moment Pelthos Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pelthos Therapeutics Inc. report Q1 2026 earnings?
Pelthos Therapeutics Inc. (PTHS) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Pelthos Therapeutics Inc.'s Q1 2026 revenue and EPS?
Pelthos Therapeutics Inc. reported revenue of $10.9M and diluted EPS of $-3.09 for Q1 2026.
Did Pelthos Therapeutics Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $10.4M by $468.3K. EPS beat the consensus estimate of $-3.45 by $0.36.
Where can I find Pelthos Therapeutics Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001919246-26-000071) and the 10-Q periodic report (0001919246-26-000070) directly on SEC EDGAR. The filing index links above go to sec.gov.